Stephanie J. Lee
Alma materHarvard School of Public Health
Stanford University School of Medicine
University of Washington
Scientific career
InstitutionsUniversity of Washington
Fred Hutchinson Cancer Research Center
WebsiteLee Lab

Stephanie J. Lee is an American haematologist and physician scientist who is Professor and Associate Director at the Fred Hutchinson Cancer Research Center. Lee works to improve the lives of blood stem cell transplant and bone marrow patients by better understanding the chronic form of graft-versus-host disease. Lee is the former President of the American Society of Hematology.

Early life and education

Lee completed her undergraduate studies at the University of Washington.[1] After graduating, she spent a year as a phlebotomist in a hospital. She pursued a medical degree at the Stanford University School of Medicine, where she completed a residency and internship.[2][3] Lee earned a Master's in Public Health from the Harvard T.H. Chan School of Public Health, and was board certified in oncology in 1997.[4] She was a medical fellow at the Dana–Farber Cancer Institute, where she was mentored by Jane Weeks and Joseph Antin.[2]

Research and career

In 2006, Lee joined the Fred Hutchinson Cancer Research Center ('the Hutch').[5][6] Lee studies bone marrow and stem cell transplantation, and ways to prevent complications during transplants.[4] In particular, she looks to understand and prevent chronic graft-versus-host disease,[7] an autoimmune disorder that occurs after allogeneic hematopoietic stem cell transplantation.[8] It can attack many different organs, and the treatment involves the use of immunosuppressive medications, rendering patients immunocompromised. Lee is the Director of the Fred Hutchinson Cancer Research Center Long-Term Follow-Up (LTFU) program,[9] which tracks over 5,000 patients who have undergone bone marrow or stem cell transplants.[10][11] Lee was named the recipient of the Giuliani/Press Endowed Chair in 2018.[5]

In 2017, Lee was elected Vice President of the American Society of Hematology, serving as President from 2020.[12][13] At the 2020 annual meeting, Lee hosted a discussion with Anthony Fauci, discussing the impact of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) on hematologic conditions.[14] During the meeting Lee and Fauci agreed that they would recommend immunocompromised patients get the COVID-19 vaccine.[15]

Selected publications

Personal life

Lee is married with two children.[2]

References

  1. "Stephanie Lee, M.D., M.P.H." Fred Hutch. Retrieved 2021-02-14.
  2. 1 2 3 admin (2015-01-01). "Pulling Back the Curtain: Stephanie Lee, MD, MPH". ASH Clinical News. Retrieved 2021-02-14.
  3. "Stephanie J. Lee MD, MPH" (PDF). CIBMTR.
  4. 1 2 "Stephanie Joi Lee M.D., M.P.H." UW Medicine. Retrieved 2021-02-14.
  5. 1 2 "Dr. Stephanie Lee honored as new Giuliani/Press Endowed Chair recipient". Fred Hutch. 2018-10-17. Retrieved 2021-02-14.
  6. "Lee joins ASH leadership team". Fred Hutch. 2007-11-01. Retrieved 2021-02-14.
  7. "Research Focus". Fred Hutch. Retrieved 2021-02-14.
  8. "What's new in combatting chronic graft-vs.-host disease". Fred Hutch. 2018-04-02. Retrieved 2021-02-14.
  9. "LTFU attending physician assumes program leadership July 1". Fred Hutch. 2013-05-06. Retrieved 2021-02-14.
  10. "Long-Term Follow-Up". Fred Hutch. Retrieved 2021-02-14.
  11. "Early detection helps manage a chronic graft-vs.-host disease complication - Fred Hutchinson Cancer Research Center". Fred Hutch. 2014-03-06. Retrieved 2021-02-14.
  12. "Stephanie Lee, MD, MPH, Elected ASH Vice President; Two Councillors Appointed to 4-Year Terms - The ASCO Post". ascopost.com. Retrieved 2021-02-14.
  13. "Stephanie Lee Begins Term as ASH President - The ASCO Post". ascopost.com. Retrieved 2021-02-14.
  14. "Fauci to be keynote speaker at ASH Annual Meeting and Exposition". www.healio.com. Retrieved 2021-02-14.
  15. "Advances in blood disorders research continue despite COVID-19". Fred Hutch. 2020-12-10. Retrieved 2021-02-14.
This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.